Unique properties of IgG4 antibody and its clinical application in autoimmune pancreatitis

References

• Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–1568.
   PubMed Web of Science ®Google Scholar
• Majumder S, Takahashi N, Chari ST. Autoimmune pancreatitis. Dig Dis Sci. 2017;62:1762–1769.
   PubMed Web of Science ®Google Scholar
• Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010–1016.
   PubMed Web of Science ®Google Scholar
• Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387–395.
   PubMed Web of Science ®Google Scholar
• Chandan VS, Iacobuzio-Donahue C, Abraham SC. Patchy distribution of pathologic abnormalities in autoimmune pancreatitis: implications for preoperative diagnosis. Am J Surg Pathol. 2008;32:1762–1769.
   PubMed Web of Science ®Google Scholar
• Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119–1127.
   PubMed Web of Science ®Google Scholar
• Zamboni G, Lüttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552–563.
   PubMed Web of Science ®Google Scholar
• Kloppel G, Detlefsen S, Chari ST, et al. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol. 2010;45:787–793.
   PubMed Web of Science ®Google Scholar
• Ku Y, Hong SM, Fujikura K, et al. IL-8 expression in granulocytic epithelial lesions of idiopathic duct-centric pancreatitis (type 2 autoimmune pancreatitis). Am J Surg Pathol. 2017;41:1129–1138.
   PubMed Web of Science ®Google Scholar
• Chari ST, Kloeppel G, Zhang L, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;39:549–554.
   PubMed Web of Science ®Google Scholar
• Aalberse RC, Van Milligen F, Tan KY, et al. Allergen-specific IgG4 in atopic disease. Allergy. 1993;48:559–569.
   PubMed Web of Science ®Google Scholar
• Aalberse RC, Stapel SO, Schuurman J, et al. Immunoglobulin G4: an odd antibody. Clin Exp Allergy. 2009;39:469–477.
   PubMed Web of Science ®Google Scholar
• Ruiter B, Knol EF, van Neerven RJ, et al. Maintenance of tolerance to cow's milk in atopic individuals is characterized by high levels of specific immunoglobulin G4. Clin Exp Allergy. 2007;37:1103–1110.
   PubMed Web of Science ®Google Scholar
• Hussain R, Poindexter RW, Ottesen EA. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol. 1992;148:2731–2737.
   PubMed Web of Science ®Google Scholar
• Yazdanbakhsh M, van den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol. 2001;22:372.
   PubMed Web of Science ®Google Scholar
• Aalberse RC, Schuurman J, van Ree R. The apparent monovalency of human IgG4 is due to bispecificity. Int Arch Allergy Immunol. 1999;118:187–189.
   PubMed Web of Science ®Google Scholar
• Rispens T, Ooievaar-De Heer P, Vermeulen E, et al. Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc–Fc interactions. J Immunol. 2009;182:4275–4281.
   PubMed Web of Science ®Google Scholar
• Clark MR. IgG effector mechanisms. Chem Immunol. 1997;65:88–110.
   PubMed Web of Science ®Google Scholar
• Bruhns P, Iannascoli B, England P, et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113:3716–3725.
   PubMed Web of Science ®Google Scholar
• Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood. 2012;119:5640–5649.
   PubMed Web of Science ®Google Scholar
• Kleger A, Seufferlein T, Wagner M, et al. IgG4-related autoimmune diseases: polymorphous presentation complicates diagnosis and treatment. Deutsches Arzteblatt Int. 2015;112:128–135.
   PubMed Web of Science ®Google Scholar
• Trampert DC, Hubers LM, van de Graaf SFJ, et al. On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease. Biochim Biophys Acta. 2018;1864:1401–1409.
   PubMed Web of Science ®Google Scholar
• Rayner LE, Hui GK, Gor J, et al. The Fab conformations in the solution structure of human immunoglobulin G4 (IgG4) restrict access to its Fc region: implications for functional activity. J Biol Chem. 2014;289:20740–20756.
   PubMed Web of Science ®Google Scholar
• Tischenko VM, Vladimir PZ, Ryazantsev SN. Human myeloma IgG4 reveals relatively rigid asymmetric Y-like structure with different conformational stability of CH2 domains. Mol Immunol. 2017;92:199–210.
   PubMed Web of Science ®Google Scholar
• Davies AM, Rispens T, Ooijevaar-de Heer P, et al. Structural determinants of unique properties of human IgG4-Fc. J Mol Biol. 2014;426:630–644.
   PubMed Web of Science ®Google Scholar
• Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology. 2002;105:9–19.
   PubMed Web of Science ®Google Scholar
• Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78:1016–1023.
   PubMed Web of Science ®Google Scholar
• Detlefsen S, Brasen JH, Zamboni G, et al. Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis. Histopathology. 2010;57:825–835.
   PubMed Web of Science ®Google Scholar
• Cornell LD, Chicano SL, Deshpande V, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol. 2007;31:1586–1597.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Watanabe H, Asano T, et al. Possible participation of IgG4 in the activation of complement in IgG4-related disease with hypocomplementemia. Mod Rheumatol. 2016;26:251–258.
   PubMed Web of Science ®Google Scholar
• Hao M, Li W, Yi L, et al. Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer. Sci Rep. 2016;6:27415.
   PubMed Web of Science ®Google Scholar
• Nirula A, Glaser SM, Kalled SL, et al. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol. 2011;23:119–124.
   PubMed Web of Science ®Google Scholar
• van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007;317:1554–1557.
   PubMed Web of Science ®Google Scholar
• Li W, Fan G, Chen L, et al. A new type of natural bispecific antibody with potential protective effect in Hashimoto thyroiditis. J Clin Endocrinol Metab. 2014;99:E1602.
   PubMed Web of Science ®Google Scholar
• Hubers LM, Vos H, Schuurman AR, et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 2018;67:728–735.
   PubMed Web of Science ®Google Scholar
• Hubers LM, Beuers U. IgG4-related disease of the biliary tract and pancreas: clinical and experimental advances. Curr Opin Gastroenterol. 2017;33:310.
   PubMed Web of Science ®Google Scholar
• Koneczny I, Stevens JA, De Rosa A, et al. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients. J Autoimmun. 2017;77:104–115.
   PubMed Web of Science ®Google Scholar
• Rispens T, den Bleker TH, Aalberse RC. Hybrid IgG4/IgG4 Fc antibodies form upon 'Fab-arm' exchange as demonstrated by SDS-PAGE or size-exclusion chromatography. Mol Immunol. 2010;47:1592–1594.
   PubMed Web of Science ®Google Scholar
• Liu H, May K. Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function. mAbs. 2012;4:17–23.
   PubMed Web of Science ®Google Scholar
• Davies AM, Rispens T, den Bleker TH, et al. Crystal structure of the human IgG4 C(H)3 dimer reveals the role of Arg409 in the mechanism of Fab-arm exchange. Mol Immunol. 2013;54:1–7.
   PubMed Web of Science ®Google Scholar
• Brusco A, Saviozzi S, Cinque F, et al. Molecular characterization of immunoglobulin G4 gene isoallotypes. Eur J Immunogenet. 1998;25:349–355.
   PubMedGoogle Scholar
• Ahmad M, Mahajan VS, Mattoo H, et al. Individuals with IgG4-related disease do not have an increased frequency of the K409 variant of IgG4 that compromises Fab-arm exchange. J Rheumatol. 2014;41:185–187.
   PubMed Web of Science ®Google Scholar
• Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas. 2006;32:16–21.
   PubMed Web of Science ®Google Scholar
• Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–738.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Naishiro Y, Suzuki C, et al. Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome. Rheumatol Int. 2010;30:565–568.
   PubMed Web of Science ®Google Scholar
• Kawa S, Hamano H, Ozaki Y, et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol. 2009;7:S18–S22.
   PubMed Web of Science ®Google Scholar
• Deshpande V, Chiocca S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–1545.
   PubMed Web of Science ®Google Scholar
• Ozawa M, Fujinaga Y, Asano J, et al. Clinical features of IgG4-related periaortitis/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study. Arthritis Res Ther. 2017;19:223.
   PubMed Web of Science ®Google Scholar
• Yi L, Hao M, Lu T, et al. Increased kappa/lambda hybrid antibody in serum is a novel biomarker related to disease activity and inflammation in rheumatoid arthritis. Mediat Inflamm. 2016;2016:2953072.
   PubMed Web of Science ®Google Scholar
• Davies AM, Jefferis R, Sutton BJ. Crystal structure of deglycosylated human IgG4-Fc. Mol Immunol. 2014;62:46–53.
   PubMed Web of Science ®Google Scholar
• Diebolder CA, Beurskens FJ, de Jong RN, et al. Complement is activated by IgG hexamers assembled at the cell surface. Science. 2014;343:1260–1263.
   PubMed Web of Science ®Google Scholar
• Corper AL, Sohi MK, Bonagura VR, et al. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody–antigen interaction. Nat Struct Mol Biol. 1997;4:374–381.
   Web of Science ®Google Scholar
• Mannik M, Nardella FA, Sasso EH. Rheumatoid factors in immune complexes of patients with rheumatoid arthritis. Springer Semin Immunopathol. 1988;10:215–230.
   PubMed Web of Science ®Google Scholar
• Mahajan VS, Mattoo H, Deshpande V, et al. IgG4-related disease. Annu Rev Pathol. 2014;9:315–347.
   PubMed Web of Science ®Google Scholar
• Chen JH, Deshpande V. IgG4-related disease and the liver. Gastroenterol Clin N Am. 2017;46:195–216.
   PubMed Web of Science ®Google Scholar
• Kamekura R, Takano K, Yamamoto M, et al. Cutting edge: a critical role of lesional T follicular helper cells in the pathogenesis of IgG4-related disease. J Immunol. 2017;199:2624–2629.
   PubMed Web of Science ®Google Scholar
• Kubo S, Nakayamada S, Zhao J, et al. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease. Rheumatology. 2018;57:514–524.
   PubMed Web of Science ®Google Scholar
• Ray K. Pancreatitis: T cells have a pivotal role in autoimmune pancreatitis in an experimental mouse model. Nat Rev Gastroenterol Hepatol. 2013;10:321.
   PubMedGoogle Scholar
• Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol. 2014;10:148–159.
   PubMed Web of Science ®Google Scholar
• Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538–1546.
   PubMed Web of Science ®Google Scholar
• Grados A, Ebbo M, Piperoglou C, et al. T cell polarization toward TH2/TFH2 and TH17/TFH17 in patients with IgG4-related disease. Front Immunol. 2017;8:235.
   PubMed Web of Science ®Google Scholar
• Koyabu M, Uchida K, Miyoshi H, et al. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases. J Gastroenterol. 2010;45:732–741.
   PubMed Web of Science ®Google Scholar
• Jeannin P, Lecoanet S, Delneste Y, et al. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 1998;160:3555–3561.
   PubMed Web of Science ®Google Scholar
• Miyoshi H, Uchida K, Taniguchi T, et al. Circulating naive and CD4 + CD25 high regulatory T cells in patients with autoimmune pancreatitis. Pancreas. 2008;36:133–140.
   PubMed Web of Science ®Google Scholar
• Punnonen J, Aversa G, Cocks BG, et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA. 1993;90:3730–3734.
   PubMed Web of Science ®Google Scholar
• Jabara HH, Loh R, Ramesh N, et al. Sequential switching from mu to epsilon via gamma 4 in human B cells stimulated with IL-4 and hydrocortisone. J Immunol. 1993;151:4528–4533.
   PubMed Web of Science ®Google Scholar
• Satoguina JS, Weyand E, Larbi J, et al. T regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J Immunol. 2005;174:4718–4726.
   PubMed Web of Science ®Google Scholar
• Kuchen S, Robbins R, Sims GP, et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol. 2007;179:5886–5896.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yamashita K, Arai Y, et al. Chronic fibro-inflammatory responses in autoimmune pancreatitis depend on IFN-alpha and IL-33 produced by plasmacytoid dendritic cells. JI. 2017;198:3886–3896.
   Google Scholar
• Mattoo H, Mahajan VS, Maehara T, et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016;138:825–838.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Moriyama M, Nakashima H, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheumat. 2012;64:254–263.
   PubMed Web of Science ®Google Scholar
• Maehara T, Moriyama M, Nakashima H, et al. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. Ann Rheum Dis. 2012;71:2011–2019.
   PubMed Web of Science ®Google Scholar
• Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425–456.
   PubMed Web of Science ®Google Scholar
• Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009;19:156–172.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504–1507.
   PubMed Web of Science ®Google Scholar
• Culver EL, Vermeulen E, Makuch M, et al. Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease. Ann Rheum Dis. 2015;74:944–947.
   PubMed Web of Science ®Google Scholar
• Zen Y, Liberal R, Nakanuma Y, et al. Possible involvement of CCL1–CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis. J Hepatol. 2013;59:1059–1064.
   PubMed Web of Science ®Google Scholar
• Akiyama M, Suzuki K, Yasuoka H, et al. Follicular helper T cells in the pathogenesis of IgG4-related disease. Rheumatology (Oxford). 2018;57:236–245.
   PubMed Web of Science ®Google Scholar
• Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, et al. Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology. 2013;57:2390–2398.
   PubMed Web of Science ®Google Scholar
• Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009;361:2135–2142.
   PubMed Web of Science ®Google Scholar
• Haldar D, Hirschfield GM. Deciphering the biology of IgG4-related disease: specific antigens and disease? Gut. 2018;67:602–605.
   PubMed Web of Science ®Google Scholar
• Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626–631.
   PubMed Web of Science ®Google Scholar
• Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan–Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol. 2008;43:403–408.
   PubMed Web of Science ®Google Scholar
• Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–358.
   PubMed Web of Science ®Google Scholar
• Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646–1653.
   PubMed Web of Science ®Google Scholar
• Sadler R, Chapman RW, Simpson D, et al. The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis. A UK Study. Eur J Gastroenterol Hepatol. 2011;23:139–145.
   PubMed Web of Science ®Google Scholar
• Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol. 2011;23:108–113.
   PubMed Web of Science ®Google Scholar
• Tabata T, Kamisawa T, Takuma K, et al. Serum IgG4 concentrations and IgG4-related sclerosing disease. Clin Chim Acta Int J Clin Chem. 2009;408:25–28.
   PubMed Web of Science ®Google Scholar
• Hart PA, Smyrk TC, Chari ST. Lymphoplasmacytic sclerosing pancreatitis without IgG4 tissue infiltration or serum IgG4 elevation: IgG4-related disease without IgG4. Mod Pathol. 2015;28:238–247.
   PubMed Web of Science ®Google Scholar
• Xia CS, Fan CH, Liu YY. Diagnostic performances of serum IgG4 concentration and IgG4/IgG ratio in IgG4-related disease. Clin Rheumatol. 2017;36:2769–2774.
   PubMed Web of Science ®Google Scholar
• Boonstra K, Culver EL, de Buy Wenniger LM, et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology. 2014;59:1954–1963.
   PubMed Web of Science ®Google Scholar
• Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Cheryk LA, Carruthers MN, et al. Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014;66:213–217.
   PubMed Web of Science ®Google Scholar
• Aoki S, Nakazawa T, Ohara H, et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera. Histopathology. 2005;47:147–158.
   PubMed Web of Science ®Google Scholar
• Shiokawa M, Kodama Y, Kuriyama K, et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut. 2016;65:1322–1332.
   PubMed Web of Science ®Google Scholar
• Koneczny I. A new classification system for IgG4 autoantibodies. Front Immunol. 2018;9:97.
   PubMed Web of Science ®Google Scholar
• Uchida K, Okazaki K, Konishi Y, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol. 2000;95:2788–2794.
   PubMed Web of Science ®Google Scholar
• Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000;118:573–581.
   PubMed Web of Science ®Google Scholar
• Aparisi L, Farre A, Gomez-Cambronero L, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut. 2005;54:703–709.
   PubMed Web of Science ®Google Scholar
• Nishi H, Tojo A, Onozato ML, et al. Anti-carbonic anhydrase II antibody in autoimmune pancreatitis and tubulointerstitial nephritis. Nephrol Dial Transplant. 2007;22:1273–1275.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Miyaji E, Morimoto K, et al. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut. 2005;54:274–281.
   PubMed Web of Science ®Google Scholar
• Takizawa S, Endo T, Wanjia X, et al. HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes. Biochem Biophys Res Commun. 2009;386:192–196.
   PubMed Web of Science ®Google Scholar
• Lohr JM, Faissner R, Koczan D, et al. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol. 2010;105:2060–2071.
   PubMed Web of Science ®Google Scholar
• Asada M, Nishio A, Uchida K, et al. Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas. 2006;33:20–26.
   PubMed Web of Science ®Google Scholar
• Endo T, Takizawa S, Tanaka S, et al. Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes. 2009;58:732–737.
   PubMed Web of Science ®Google Scholar
• Itoh Y, Reichlin M. Antibodies to carbonic anhydrase in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum. 1992;35:73–82.
   PubMed Web of Science ®Google Scholar
• Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83:455–462.
   PubMed Web of Science ®Google Scholar
• Rock B, Martins CR, Theofilopoulos AN, et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med. 1989;320:1463–1469.
   PubMed Web of Science ®Google Scholar
• Warren SJ, Arteaga LA, Rivitti EA, et al. The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol. 2003;120:104–108.
   PubMed Web of Science ®Google Scholar
• Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med. 2006;355:1800–1810.
   PubMed Web of Science ®Google Scholar
• Hirano K, Komatsu Y, Yamamoto N, et al. Pancreatic mass lesions associated with raised concentration of IgG4. Am J Gastroenterol. 2004;99:2038–2040.
   PubMed Web of Science ®Google Scholar
• Pak LM, Schattner MA, Balachandran V, et al. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. HPB. 2018;20:182–187.
   PubMed Web of Science ®Google Scholar
• Ngwa T, Law R, Hart P, et al. Serum IgG4 elevation in pancreatic cancer: diagnostic and prognostic significance and association with autoimmune pancreatitis. Pancreas. 2015;44:557–560.
   PubMed Web of Science ®Google Scholar
• Moon SH, Kim MH, Park DH, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut. 2008;57:1704–1712.
   PubMed Web of Science ®Google Scholar
• Gardner TB, Levy MJ, Takahashi N, et al. Misdiagnosis of autoimmune pancreatitis: a caution to clinicians. Am J Gastroenterol. 2009;104:1620–1623.
   PubMed Web of Science ®Google Scholar
• Yan T, Ke Y, Chen Y, et al. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin. PLoS One. 2017;12:e0174735.
   PubMed Web of Science ®Google Scholar
• Chang MC, Liang PC, Jan S, et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Pancreatology. 2014;14:366–372.
   PubMed Web of Science ®Google Scholar
• van Heerde MJ, Buijs J, Hansen BE, et al. Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma. Dig Dis Sci. 2014;59:1322–1329.
   PubMed Web of Science ®Google Scholar
• Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403–1404.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Mattoo H, Mahajan VS, et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology. 2016;55:1000–1008.
   PubMed Web of Science ®Google Scholar
• Handa T, Matsui S, Yoshifuji H, et al. Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. Mod Rheumatol. 2018;1–7. DOI:10.1080/14397595.2017.1416739
   PubMed Web of Science ®Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–551.
   PubMed Web of Science ®Google Scholar
• Mayerle J, Lerch MM, Greinacher A. Why is one arm stronger than two arms? IgG4 antibodies in IgG4-related autoimmune pancreatitis. Gut. 2016;65:1240–1241.
   PubMed Web of Science ®Google Scholar
• Masaki Y, Shimizu H, Sato Nakamura T, et al. IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. J Clin Exp Hematopathol. 2014;54:95–101.
   PubMedGoogle Scholar
• Kamisawa T, Imai M, Egawa N, et al. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2008;20:1167–1170.
   PubMed Web of Science ®Google Scholar
• Erkelens GW, Vleggaar FP, Lesterhuis W, et al. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet. 1999;354:43–44.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Ohara H, Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepato-Gastroenterology. 2001;48:625–630.
   PubMedGoogle Scholar
• Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52:683–687.
   PubMed Web of Science ®Google Scholar
• Saegusa H, Momose M, Kawa S, et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas. 2003;27:20–25.
   PubMed Web of Science ®Google Scholar
• Kaji R, Takedatsu H, Okabe Y, et al. Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients. J Gastroenterol Hepatol. 2012;27:268–272.
   PubMed Web of Science ®Google Scholar
• Culver EL, Sadler R, Simpson D, et al. Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort. Am J Gastroenterol. 2016;111:733–743.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Egawa N, Nakajima H, et al. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol. 2004;39:1154–1158.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961–970.
   PubMed Web of Science ®Google Scholar
• Kubota K, Watanabe S, Uchiyama T, et al. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids. J Gastroenterol. 2011;46:834–842.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755–1762.
   PubMed Web of Science ®Google Scholar